Bright Peak Therapeutics to Participate in 43rd Annual J.P. Morgan Healthcare Conference
BASEL, Switzerland and SAN DIEGO, Jan. 6 (Korea Bizwire) — Bright Peak Therapeutics, a clinical-stage biotechnology company focused on discovering and developing multifunctional immunotherapies for cancer, today announced that Fredrik Wiklund, Chief Executive Officer, will present at the 43rd Annual J.P. Morgan Healthcare Conference on Tuesday, January 14th, 2025, at 2:30 p.m. Pacific Time. The Company [...]